Harvest Technologies has received FDA authorization to commence the first clinical trials with autologous adult stem cells in the treatment of critical limb ischemia.
Scientists increase the efficacy of mesenchymal stem cells through a process of molecular “supercharging” for the therapeutic regeneration of heart tissue following myocardial infarction.
The renowned adult stem cell expert, Dr. Colin McGuckin of Newcastle, England is permanently relocating his laboratory and staff to France, citing an unjustified bias toward embryonic stem cell research in the UK, to the detriment of adult stem cell work.
A molecular link has been found between specific genes that regulate aging, cancer, and stem cell activity.
Scientists report a new and highly efficient, improved procedure for the reprogramming of adult human somatic cells into iPS (induced pluripotent stem) cells.
Now that it is possible to create pluripotent stem cells without the need for embryos, stem cell research labs are springing up by the hundreds – despite the fact that one critical problem still remains.
